ESC 365 - Anticoagulation/avoid stroke in patients with valvular heart disease.

Open Access

Anticoagulation/avoid stroke in patients with valvular heart disease.

Session: 2021 ESC/EACTS Guidelines for the management of valvular heart disease

Topic: Valvular Heart Disease, Other

Speaker: Professor D. Capodanno (Catania, IT)

Event: ESC Congress 2021 - The Digital Experience

Congress Session

About the speaker

Professor Davide Capodanno

University of Catania, Catania (Italy)

26 presentations

4 followers

4 more presentations in this session

Timing and indication of intervention in asymptomatic patients with valvular heart disease.

Speaker: Doctor V. Delgado (Barcelona, ES)

Mode of intervention in aortic stenosis.

Speaker: Professor B. Prendergast (London, GB)

Mode of intervention in mitral regurgitation.

Speaker: Doctor F. Praz (Bern, CH)

2021 ESC/EACTS Guidelines for the management of valvular heart disease - panel.

Access the full session

2021 ESC/EACTS Guidelines for the management of valvular heart disease

Speakers: Professor D. Capodanno, Doctor V. Delgado, Professor B. Prendergast, Doctor F. Praz

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

EHRA Premium Access

Long QT syndrome.

5 April 2022

ACVC Premium Access

The patient with acute myocarditis.

19 March 2022

ACVC Premium Access

Management of acute pericarditis refractory to first-line treatments.

19 March 2022

This platform is supported by